longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AUTL

AUTL
----

LongbridgeAI

Autolus enters up to USD 250 million senior secured notes facility with Perceptive Credit Holdings V

PUBT
Aug 3, 2026 at 11:04 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Autolus Therapeutics has entered into a senior secured notes facility with Perceptive Credit Holdings V, totaling up to USD 250 million. The company issued USD 75 million in Tranche 1 Notes on July 30, 2026, with an additional USD 175 million available across three tranches until January 30, 2027. The facility matures on July 30, 2031, carrying an interest rate of 6.75%-7.25% over SOFR or 3.5%. It is secured by a first-priority lien on substantially all assets and includes specific liquidity and revenue covenants.

  • Autolus entered a Perceptive senior secured notes facility for up to USD 250 million, issuing USD 75 million of Tranche 1 Notes on July 30, 2026. * Facility allows up to USD 175 million more across three tranches, including USD 25 million available through Jan. 30, 2027. * Matures July 30, 2031; interest is 6.75%-7.25% margin over the greater of 1-month term SOFR or 3.5%. * No scheduled principal amortization before maturity; early redemption allowed with a 1%-8% premium. * Secured by a first-priority lien on substantially all assets; includes minimum liquidity and consolidated net revenue covenants. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autolus Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-329526), on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Login to unlock856characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Autolus Therapeutics

Autolus Therapeutics

AUTL.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--